CSHL Stories and Media archive for Tag: CSHL Cancer Center

CSHL announces AACR Cancer Centers Alliance

9/18/2023

The new initiative, led by CSHL Professor David Tuveson, seeks to unite the nation’s NCI-designated cancer centers to help save more patients’ lives. Read the story »

In cancer immunotherapy, more isn’t necessarily better

9/14/2023

CSHL Assistant Professor Peter Westcott may have discovered why immunotherapy often fails in certain colon cancer treatments. Read the story »

CSHL makes a splash with Swim Across America

8/21/2023

Since 1987, the charity swim has raised over $100 million for cancer research. Here, CSHL Assistant Professor Semir Beyaz voices his support. Watch the video »

Metastatic breast cancer’s Trojan horse

7/26/2023

CSHL and Massachusetts General Hospital researchers uncover how metastatic breast cancer slips past the immune system’s defenses in mice. Read the story »

Lingbo Zhang wins National Institutes of Health MERIT Award

6/15/2023

The highly prestigious award will support Zhang’s research on the role of nutrients and other environmental factors in blood cancer development. Read the story »

David Tuveson wins 2022 Luminary Award

11/17/2022

The award, presented on World Pancreatic Cancer Day, honors Tuveson for his efforts to find a cure and improve patients’ lives. Read the story »

David Tuveson elected to National Academy of Medicine

10/17/2022

Tuveson was recognized for his pioneering cancer organoid research that led to the development of the first mouse models for pancreatic cancer. Read the story »

Immunologist Peter Westcott joins CSHL faculty

9/12/2022

The Westcott lab explores how the immune system shapes tumor evolution, with the goal of developing new cancer immunotherapies. Read the story »

Cancer has a lot of nerve

8/22/2022

Tumors recruit the nervous system to help them spread. Scientists are looking for ways to stop it. Read the story »

Tobias Janowitz leads new, global Cancer Grand Challenges team

6/16/2022

Janowitz received a $25 million grant to take on cachexia. This debilitating condition is responsible for up to 30% of cancer-related deaths. Read the story »

President’s essay: Foundations for the future

5/25/2022

Strategically designed to spark scientific exchange and inspiration, CSHL is a unique research and education environment for advancing science. Read the story »

Copper, cancer, and COVID-19: The story of an idea, a meeting, and a paper

3/4/2022

The Copper Cancer Consortium started as a new treatment concept and is now a published paper. Read the story of Banbury's last meeting before COVID. Read the story »

CSHL receives 2021 NCI grant of $4.5 million

10/1/2021

The National Cancer Institute renewed its Basic Laboratory Cancer Center grant for CSHL, marking 34 years of our continued progress in cancer research. Read the story »

Frontiers of cancer research quiz

Test your knowledge of the newest developments in cancer research with some science trivia. Take the quiz »

CSHL organoid facility: Cancer custodians

7/2/2021

To beat our worst enemy, we must first let it grow. Read the story »